Selected research
Industry Growth & Trends
Global TACE Embolic Microspheres Industry Growth and Trends Forecast to 2032
Market perspective
The global TACE Embolic Microspheres market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of TACE Embolic Microspheres include ABK Biomedical, Boston Scientific, Merit Medical, Mermaid Medical, Sirtex Medical, Terumo, Varian, Cardiolink Science and Suzhou Hengrui Medical Equipment, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global TACE Embolic Microspheres market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The TACE Embolic Microspheres market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global TACE Embolic Microspheres market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to TACE Embolic Microspheres.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global TACE Embolic Microspheres market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
TACE Embolic Microspheres Market by Company
ABK Biomedical
Boston Scientific
Merit Medical
Mermaid Medical
Sirtex Medical
Terumo
Varian
Cardiolink Science
Suzhou Hengrui Medical Equipment
TACE Embolic Microspheres Segment by Type
Common Embolic Microspheres
Drug-Loadable Embolic Microspheres
TACE Embolic Microspheres Segment by Application
Colorectal Cancer Liver Metastasis
Primary Liver Cancer
Others
TACE Embolic Microspheres Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TACE Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TACE Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TACE Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TACE Embolic Microspheres manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of TACE Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Common Embolic Microspheres
- Drug-Loadable Embolic Microspheres
Applications
- Colorectal Cancer Liver Metastasis
- Primary Liver Cancer
- Others
Companies covered
- ABK Biomedical
- Boston Scientific
- Merit Medical
- Mermaid Medical
- Sirtex Medical
- Terumo
- Varian
- Cardiolink Science
- Suzhou Hengrui Medical Equipment
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global TACE Embolic Microspheres Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global TACE Embolic Microspheres Sales Estimates and Forecasts (2021-2032)
- 1.3 TACE Embolic Microspheres Market by Type
- 1.3.1 Common Embolic Microspheres
- 1.3.2 Drug-Loadable Embolic Microspheres
- 1.4 Global TACE Embolic Microspheres Market Size by Type
- 1.4.1 Global TACE Embolic Microspheres Market Size Overview by Type (2021-2032)
- 1.4.2 Global TACE Embolic Microspheres Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global TACE Embolic Microspheres Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America TACE Embolic Microspheres Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe TACE Embolic Microspheres Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific TACE Embolic Microspheres Sales Breakdown by Type (2021-2026)
- 1.5.4 South America TACE Embolic Microspheres Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa TACE Embolic Microspheres Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 TACE Embolic Microspheres Industry Trends
- 2.2 TACE Embolic Microspheres Industry Drivers
- 2.3 TACE Embolic Microspheres Industry Opportunities and Challenges
- 2.4 TACE Embolic Microspheres Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by TACE Embolic Microspheres Revenue (2021-2026)
- 3.2 Global Top Players by TACE Embolic Microspheres Sales (2021-2026)
- 3.3 Global Top Players by TACE Embolic Microspheres Price (2021-2026)
- 3.4 Global TACE Embolic Microspheres Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global TACE Embolic Microspheres Major Company Production Sites & Headquarters
- 3.6 Global TACE Embolic Microspheres Company, Product Type & Application
- 3.7 Global TACE Embolic Microspheres Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global TACE Embolic Microspheres Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 TACE Embolic Microspheres Players Market Share by Revenue in 2025
- 3.8.3 2025 TACE Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 TACE Embolic Microspheres Regional Status and Outlook
- 4.1 Global TACE Embolic Microspheres Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global TACE Embolic Microspheres Historic Market Size by Region
- 4.2.1 Global TACE Embolic Microspheres Sales in Volume by Region (2021-2026)
- 4.2.2 Global TACE Embolic Microspheres Sales in Value by Region (2021-2026)
- 4.2.3 Global TACE Embolic Microspheres Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global TACE Embolic Microspheres Forecasted Market Size by Region
- 4.3.1 Global TACE Embolic Microspheres Sales in Volume by Region (2027-2032)
- 4.3.2 Global TACE Embolic Microspheres Sales in Value by Region (2027-2032)
- 4.3.3 Global TACE Embolic Microspheres Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 TACE Embolic Microspheres by Application
- 5.1 TACE Embolic Microspheres Market by Application
- 5.1.1 Colorectal Cancer Liver Metastasis
- 5.1.2 Primary Liver Cancer
- 5.1.3 Others
- 5.2 Global TACE Embolic Microspheres Market Size by Application
- 5.2.1 Global TACE Embolic Microspheres Market Size Overview by Application (2021-2032)
- 5.2.2 Global TACE Embolic Microspheres Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global TACE Embolic Microspheres Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America TACE Embolic Microspheres Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe TACE Embolic Microspheres Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific TACE Embolic Microspheres Sales Breakdown by Application (2021-2026)
- 5.3.4 South America TACE Embolic Microspheres Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa TACE Embolic Microspheres Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 ABK Biomedical
- 6.1.1 ABK Biomedical Company Information
- 6.1.2 ABK Biomedical Business Overview
- 6.1.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
- 6.1.5 ABK Biomedical Recent Developments
- 6.2 Boston Scientific
- 6.2.1 Boston Scientific Company Information
- 6.2.2 Boston Scientific Business Overview
- 6.2.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
- 6.2.5 Boston Scientific Recent Developments
- 6.3 Merit Medical
- 6.3.1 Merit Medical Company Information
- 6.3.2 Merit Medical Business Overview
- 6.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
- 6.3.5 Merit Medical Recent Developments
- 6.4 Mermaid Medical
- 6.4.1 Mermaid Medical Company Information
- 6.4.2 Mermaid Medical Business Overview
- 6.4.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
- 6.4.5 Mermaid Medical Recent Developments
- 6.5 Sirtex Medical
- 6.5.1 Sirtex Medical Company Information
- 6.5.2 Sirtex Medical Business Overview
- 6.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
- 6.5.5 Sirtex Medical Recent Developments
- 6.6 Terumo
- 6.6.1 Terumo Company Information
- 6.6.2 Terumo Business Overview
- 6.6.3 Terumo TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Terumo TACE Embolic Microspheres Product Portfolio
- 6.6.5 Terumo Recent Developments
- 6.7 Varian
- 6.7.1 Varian Company Information
- 6.7.2 Varian Business Overview
- 6.7.3 Varian TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Varian TACE Embolic Microspheres Product Portfolio
- 6.7.5 Varian Recent Developments
- 6.8 Cardiolink Science
- 6.8.1 Cardiolink Science Company Information
- 6.8.2 Cardiolink Science Business Overview
- 6.8.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
- 6.8.5 Cardiolink Science Recent Developments
- 6.9 Suzhou Hengrui Medical Equipment
- 6.9.1 Suzhou Hengrui Medical Equipment Company Information
- 6.9.2 Suzhou Hengrui Medical Equipment Business Overview
- 6.9.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
- 6.9.5 Suzhou Hengrui Medical Equipment Recent Developments
7 North America by Country
- 7.1 North America TACE Embolic Microspheres Sales by Country
- 7.1.1 North America TACE Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America TACE Embolic Microspheres Sales by Country (2021-2026)
- 7.1.3 North America TACE Embolic Microspheres Sales Forecast by Country (2027-2032)
- 7.2 North America TACE Embolic Microspheres Market Size by Country
- 7.2.1 North America TACE Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America TACE Embolic Microspheres Market Size by Country (2021-2026)
- 7.2.3 North America TACE Embolic Microspheres Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe TACE Embolic Microspheres Sales by Country
- 8.1.1 Europe TACE Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe TACE Embolic Microspheres Sales by Country (2021-2026)
- 8.1.3 Europe TACE Embolic Microspheres Sales Forecast by Country (2027-2032)
- 8.2 Europe TACE Embolic Microspheres Market Size by Country
- 8.2.1 Europe TACE Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe TACE Embolic Microspheres Market Size by Country (2021-2026)
- 8.2.3 Europe TACE Embolic Microspheres Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific TACE Embolic Microspheres Sales by Country
- 9.1.1 Asia-Pacific TACE Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific TACE Embolic Microspheres Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific TACE Embolic Microspheres Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific TACE Embolic Microspheres Market Size by Country
- 9.2.1 Asia-Pacific TACE Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific TACE Embolic Microspheres Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific TACE Embolic Microspheres Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America TACE Embolic Microspheres Sales by Country
- 10.1.1 South America TACE Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America TACE Embolic Microspheres Sales by Country (2021-2026)
- 10.1.3 South America TACE Embolic Microspheres Sales Forecast by Country (2027-2032)
- 10.2 South America TACE Embolic Microspheres Market Size by Country
- 10.2.1 South America TACE Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America TACE Embolic Microspheres Market Size by Country (2021-2026)
- 10.2.3 South America TACE Embolic Microspheres Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa TACE Embolic Microspheres Sales by Country
- 11.1.1 Middle East and Africa TACE Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa TACE Embolic Microspheres Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa TACE Embolic Microspheres Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa TACE Embolic Microspheres Market Size by Country
- 11.2.1 Middle East and Africa TACE Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa TACE Embolic Microspheres Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa TACE Embolic Microspheres Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 TACE Embolic Microspheres Value Chain Analysis
- 12.1.1 TACE Embolic Microspheres Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 TACE Embolic Microspheres Production Mode & Process
- 12.2 TACE Embolic Microspheres Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 TACE Embolic Microspheres Distributors
- 12.2.3 TACE Embolic Microspheres Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst